» Sponsored ads

» Sponsored ads

» Sponsored ads


Go Back   Cafepharma Message Boards > Pharma/Biotech Companies > Pan American Laboratories
Register Members List Calendar Search Today's Posts Mark Forums Read

Pan American Laboratories Anonymous board for Pan American Labs

Reply

 
Bookmark and Share Thread Tools Rate Thread Display Modes
  #1  
Old 04-29-2011, 10:16 PM
Anonymous
 
Posts: n/a
Default Metanx DID NOT IMPROVE endpoint!

SAN DIEGO -- A prescription medical food that provides active forms of folate and vitamins B6 and B12 may provide some relief for patients with diabetic peripheral neuropathy, a placebo-controlled trial showed.
But Metanx -- which contains L-methylfolate calcium, pyridoxal-5'-phosphate, and methylcobalamin -- did not improve the primary endpoint of the perception of vibration compared with placebo, according to Vivian Fonseca, MD, of Tulane University in New Orleans.
There were, however, some important improvements on secondary endpoints of neuropathic symptoms and health-related quality of life, he reported at the American Association of Clinical Endocrinologists meeting here.
In an interview, he said he thinks the results warrant further study, perhaps with a different primary endpoint.
Fonseca said Metanx -- which is approved by the FDA and is indicated for the management of the nutritional requirements of patients with endothelial dysfunction, elevated homocysteine levels, or both who present with symptoms of diabetic peripheral neuropathy or lower extremity ulcerations -- might affect neuropathy because of the role vitamins play in nerve metabolism.
Many diabetic patients have vitamin deficiencies, he said, noting that metformin lowers level of vitamin B12, which might affect nerve function.
"It's not something we've paid a lot of attention to, but it might contribute in some way to the patient's neuropathy being worse," said Fonseca, who is president-elect for medicine and science of the American Diabetes Association.
For now, clinicians might consider using Metanx for their patients with diabetic peripheral neuropathy to see whether it makes the patients feel better, he said.
"It's available and there's nothing else" for diabetic neuropathy, Fonseca said, who acknowledged that because of the failure of Metanx to affect vibration perception there is no objective way to tell whether it is working.
But, he said, "ultimately what matters is that the patients get better."
The trial was a 24-week, double-blind, placebo-controlled study of 214 patients with type 2 diabetic peripheral neuropathy and a baseline vibration perception threshold of 25 to 45 volts. Their mean age was 62.6 (range 25 to 80), the mean duration of diabetes was 11.5 years, and symptoms of neuropathy were present for an average of 6.1 years.
Either Metanx or placebo was taken orally twice a day. Medication compliance exceeded 95% in both groups.
Patients were allowed to use other medications for diabetic peripheral neuropathy as long as the doses remained constant during the study.
After 24 weeks, there was no difference between the groups in vibration perception threshold.
"It did not change, but that's okay," Fonseca said. "There is no study for any drug in neuropathy that changes things like nerve conduction or vibration consistently in humans."
There was, however, greater improvement with Metanx than with placebo on the Neuropathy Total Symptom Score-6 (at both 16 and 24 weeks), the Neuropathy Disability Score (at 16 weeks), and the mental component of the Short Form-36 Health Survey (at 24 weeks) (P<0.05 for all).
Fonseca said that the doses of vitamins in Metanx will not cause toxicity, and that adverse events were infrequent in both arms of the study. No patients withdrew because of adverse events.
The most common combined adverse events were infections and infestations (5.6%), injury, poisoning, and procedural complications (4.2%), and general disorders and administration site conditions (3.3%).
Reply With Quote
  #2  
Old 04-30-2011, 12:24 AM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

Medical Food (Metanx) Fails to Achieve 24-Week Efficacy Versus Placebo for Diabetic Peripheral Neuropathy
Reply With Quote
  #3  
Old 05-06-2011, 11:54 PM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

Hope this is not a shock to you!! Everyone knew this back in 2001.....
Reply With Quote
  #4  
Old 08-23-2011, 11:22 PM
Anonymous
 
Posts: n/a
Banghead Re: Metanx DID NOT IMPROVE endpoint!

"Fonseca said Metanx -- which is approved by the FDA and is indicated for the management of the nutritional requirements ..."

This product and all of the other "Medical Foods" you sell are not approved by the FDA. I wonder when the FDA is going to clamp down on this bullshit. When is the federal government going to prosecute you guys for listing the product as an Rx and getting reimbursement, when its a FUCKING VITAMIN??? It's a Dietary Supplement and should be labeled with Supplement Facts and sold as an OTC.

Please look on FDA.GOV and look up Mentanx and any other one of your products. If its approved by the FDA, it listed with the NDA # and the approval letter. This use of "Medical Foods" is at most a overlooked technicality and is really just FRAUD. What a piece of shit company!!! Sell weed; its more honorable.
Reply With Quote
  #5  
Old 08-27-2011, 02:18 PM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

"but hey what will it hurt" remember that back in the day? "Come on Doctor just give it a try and do your own test with your patients"..... "Its only 20$ per month its nothing" Just give it a try...... This companies ethics are sick!
Reply With Quote
  #6  
Old 08-28-2011, 02:32 PM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

Quote:
Originally Posted by Anonymous View Post
"Fonseca said Metanx -- which is approved by the FDA and is indicated for the management of the nutritional requirements ..."

This product and all of the other "Medical Foods" you sell are not approved by the FDA. I wonder when the FDA is going to clamp down on this bullshit. When is the federal government going to prosecute you guys for listing the product as an Rx and getting reimbursement, when its a FUCKING VITAMIN??? It's a Dietary Supplement and should be labeled with Supplement Facts and sold as an OTC.

Please look on FDA.GOV and look up Mentanx and any other one of your products. If its approved by the FDA, it listed with the NDA # and the approval letter. This use of "Medical Foods" is at most a overlooked technicality and is really just FRAUD. What a piece of shit company!!! Sell weed; its more honorable.
quit hiding behind a message board......it's much more honorable than bitching and moaning
Reply With Quote
  #7  
Old 08-29-2011, 12:24 PM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

Quote:
Originally Posted by Anonymous View Post
quit hiding behind a message board......it's much more honorable than bitching and moaning
How much is a 1/4 of Pamlab weed? LOL
Reply With Quote
  #8  
Old 10-06-2011, 10:55 PM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

None of these "products" are proven to do anything. Scam Labs.
Reply With Quote
  #9  
Old 10-07-2011, 09:17 AM
Anonymous
 
Posts: n/a
Default Re: Metanx DID NOT IMPROVE endpoint!

Quote:
Originally Posted by Anonymous View Post
"but hey what will it hurt" remember that back in the day? "Come on Doctor just give it a try and do your own test with your patients"..... "Its only 20$ per month its nothing" Just give it a try...... This companies ethics are sick!
These pal turds are the best!!! You guys get laptops yet? How's that sweet budget and lack of respect? Any meetings at motel 6.....fucking losers. Pal pal pal!!!
Reply With Quote
Reply




Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may post new threads
You may post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 02:16 PM.


Powered by vBulletin® Version 3.6.11
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.